This page screens the US healthcare sector for companies generating strong return on equity, refreshed automatically from live data.
DeltaScreener currently builds this page from your US-listed stock universe using the following rules:
Top sectors in the current result set: Healthcare (25).
Click any ticker to open the full stock detail page with financials, valuation history, and more.
| # | Ticker | Company | Exchange | Price | Market Cap | P/E | P/B | ROE | ROA | Net Margin | D/E |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MEDP | Medpace Holdings, Inc. | NASDAQ | $602.70 | $16.82B | 35.86 | 40.69 | 110.15% | 23.89% | 17.67% | 0.28 |
| 2 | FBIO | Fortress Biotech, Inc. | NASDAQ | $2.09 | $69.4M | 0.64 | 0.4 | 103.52% | 35.31% | 163.32% | 0.39 |
| 3 | RIGL | Rigel Pharmaceuticals, Inc. | NMS | $48.72 | $901.4M | 2.67 | 2.05 | 96.49% | 61.78% | 116.30% | 0.09 |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | NASDAQ | $224.53 | $30.04B | 36.02 | 21.62 | 93.61% | 14.54% | 16.82% | 0.94 |
| 5 | LLY | Eli Lilly and Company | NYSE | $1,169.93 | $1.10T | 39.6 | 31.18 | 92.58% | 18.77% | 33.53% | 1.62 |
| 6 | QTTB | Q32 Bio Inc. | NASDAQ | $8.09 | $240.8M | 2.95 | 1.1 | 76.88% | 29.16% | 62.87% | 0.05 |
| 7 | ORMP | Oramed Pharmaceuticals Inc. | NASDAQ | $4.20 | $171.9M | 1.06 | 0.58 | 72.96% | 47.31% | — | 0.01 |
| 8 | TGTX | TG Therapeutics, Inc. | NASDAQ | $53.34 | $8.17B | 17.83 | 12.74 | 72.30% | 26.93% | 55.22% | 1.25 |
| 9 | IDXX | IDEXX Laboratories, Inc. | NASDAQ | $513.14 | $40.48B | 36.46 | 25.79 | 71.96% | 33.11% | 25.03% | 0.68 |
| 10 | ZTS | Zoetis Inc. | NYSE | $73.08 | $30.64B | 11.69 | 9.43 | 69.25% | 17.35% | 27.49% | 2.93 |
| 11 | NVO | Novo Nordisk A/S | NYSE | $38.18 | $169.54B | 9.65 | 5.06 | 59.09% | 19.57% | 35.35% | 0.63 |
| 12 | AUPH | Aurinia Pharmaceuticals Inc | NASDAQ | $16.22 | $2.09B | 6.71 | 3.35 | 59.00% | 39.65% | 100.84% | 0.1 |
| 13 | NUTX | Nutex Health Inc. | NASDAQ | $205.01 | $1.41B | 8.21 | 3.75 | 51.88% | 18.65% | 21.25% | 0.88 |
| 14 | THC | Tenet Healthcare Corporation | NYSE | $260.57 | $20.98B | 9.93 | 4.65 | 50.63% | 7.31% | 10.27% | 2.84 |
| 15 | BMY | Bristol-Myers Squibb Company | NYSE | $59.58 | $121.70B | 13.85 | 5.75 | 46.75% | 10.59% | 18.87% | 1.93 |
| 16 | CRMD | CorMedix Inc. | NASDAQ | $7.32 | $574.3M | 3.01 | 1.24 | 44.64% | 20.70% | 40.49% | 0.31 |
| 17 | CGEN | Compugen Ltd. | NASDAQ | $2.12 | $200.5M | 6.15 | 2.46 | 42.57% | 25.43% | 47.55% | 0.03 |
| 18 | EXEL | Exelixis, Inc. | NASDAQ | $59.02 | $14.83B | 17.78 | 7.96 | 42.49% | 34.50% | 35.33% | 0.09 |
| 19 | ADMA | ADMA Biologics Inc | NASDAQ | $10.33 | $2.39B | 14.08 | 5.67 | 39.59% | 24.69% | 32.98% | 0.5 |
| 20 | DXCM | DexCom, Inc. | NASDAQ | $84.41 | $31.85B | 33.44 | 12.68 | 36.19% | 15.49% | 20.12% | 0.53 |
| 21 | TMDX | TransMedics Group, Inc. | NASDAQ | $79.00 | $2.73B | 18.5 | 5.46 | 32.97% | 10.36% | 22.69% | 1.67 |
| 22 | ZVRA | Zevra Therapeutics, Inc. | NASDAQ | $11.00 | $650.3M | 10.4 | 2.72 | 32.77% | 19.25% | 42.82% | 0.01 |
| 23 | ACAD | ACADIA Pharmaceuticals Inc. | — | $19.58 | $3.35B | 8.87 | 2.62 | 32.39% | 21.83% | 33.42% | 0.06 |
| 24 | ILMN | Illumina, Inc. | NASDAQ | $264.57 | $40.03B | 49.91 | 14.37 | 31.08% | 12.41% | 18.36% | 0.89 |
| 25 | PDEX | Pro-Dex, Inc. | NASDAQ | $62.21 | $198.6M | 15.49 | 4.43 | 31.05% | 18.34% | 17.62% | 0.38 |